Tiqui, Maria Akhiera Zhy S.
HRN: 22-39-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
AMPICILLIN 1GM (VIAL)
01/18/2023
01/24/2023
IV
150mg
Q12
MAS
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes